GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » King International Investment Ltd (HKSE:00928) » Definitions » 3-Year FCF Growth Rate

King International Investment (HKSE:00928) 3-Year FCF Growth Rate : 0.00% (As of Sep. 2023)


View and export this data going back to 2002. Start your Free Trial

What is King International Investment 3-Year FCF Growth Rate?

King International Investment's Free Cash Flow per Share for the six months ended in Sep. 2023 was HK$-0.01.

During the past 12 months, King International Investment's average Free Cash Flow per Share Growth Rate was -291.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of King International Investment was 68.60% per year. The lowest was -61.30% per year. And the median was 10.50% per year.


Competitive Comparison of King International Investment's 3-Year FCF Growth Rate

For the Diagnostics & Research subindustry, King International Investment's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


King International Investment's 3-Year FCF Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, King International Investment's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where King International Investment's 3-Year FCF Growth Rate falls into.



King International Investment 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


King International Investment  (HKSE:00928) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


King International Investment 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of King International Investment's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


King International Investment (HKSE:00928) Business Description

Traded in Other Exchanges
N/A
Address
18 Harbour Road, Room 6307-08, 63rd Floor, Central Plaza, Wanchai, Hong Kong, HKG
King International Investment Ltd formerly Life Healthcare Group Ltd is an investment holding company. The company's operating segment includes the Healthcare products and services business and Money lending business. It generates maximum revenue from the Healthcare products and services business segment. Geographically, it derives a majority of revenue from PRC. The group is primarily a provider of genetic testing and health data analysis services.
Executives
Wei Yan 2101 Beneficial owner
Wang Mengyao 2101 Beneficial owner
Wong Yat Fung 2101 Beneficial owner
Zhou Chun Yan 2101 Beneficial owner
Pioneer Environmental International Industries Company Limited 2101 Beneficial owner
Liu Na 2201 Interest of corporation controlled by you
Wang Wen 2101 Beneficial owner
Pang Zhen 2101 Beneficial owner

King International Investment (HKSE:00928) Headlines

No Headlines